Status: current, Defined. Date: 31-May 2013. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 546651000036116 | doxorubicin hydrochloride (as pegylated liposomal) (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 546661000036118 | doxorubicin hydrochloride (as pegylated liposomal) | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| doxorubicin hydrochloride (as pegylated liposomal) | Is a | medicinal product | true | Inferred relationship | Some | ||
| doxorubicin hydrochloride (as pegylated liposomal) | has intended active ingredient | doxorubicin hydrochloride (as pegylated liposomal) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, vial | Is a | True | doxorubicin hydrochloride (as pegylated liposomal) | Inferred relationship | Some | |
| doxorubicin hydrochloride (as pegylated liposomal) 50 mg/25 mL injection, vial | Is a | True | doxorubicin hydrochloride (as pegylated liposomal) | Inferred relationship | Some |
Reference Sets
Medicinal product reference set
FHIR